Atia Vision

Atia Vision, Inc. is a clinical-stage ophthalmic medical device company headquartered in Campbell, California, and a portfolio company of the Shifamed medical innovation hub. It develops the OmniVu modular shape-changing intraocular lens (IOL) — a two-part implant pairing a fluid-filled, shape-changing base with an exchangeable fixed-power front optic — designed to work with the eye's natural accommodative mechanism to restore a full range of functional vision in cataract patients, and implanted using conventional cataract surgical technique. The company raised a $20M Series D and a $42M Series E, and in May 2025 the U.S. Food and Drug Administration granted it an Investigational Device Exemption to begin a feasibility clinical study of the OmniVu Lens System; the device is investigational and is not approved for sale or use in the United States. Atia Vision is an implantable-device manufacturer: it publishes no developer program, no public API, and no machine-readable specification.

Atia Vision is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Ophthalmology, Intraocular Lens, and Cataract Surgery.

🌐 Visit website 📡 Source on GitHub

5.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyMedical DevicesOphthalmologyIntraocular LensCataract SurgeryHealthClinical Stage

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 5.1/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Commercial Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 3.9 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/atia-vision: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 2

The organization behind the API

Website

Website

LinkedIn

Source (apis.yml)

aid: atia-vision
name: Atia Vision
description: 'Atia Vision, Inc. is a clinical-stage ophthalmic medical device company headquartered in Campbell, California,
  and a portfolio company of the Shifamed medical innovation hub. It develops the OmniVu modular shape-changing intraocular
  lens (IOL) — a two-part implant pairing a fluid-filled, shape-changing base with an exchangeable fixed-power front optic
  — designed to work with the eye''s natural accommodative mechanism to restore a full range of functional vision in cataract
  patients, and implanted using conventional cataract surgical technique. The company raised a $20M Series D and a $42M Series
  E, and in May 2025 the U.S. Food and Drug Administration granted it an Investigational Device Exemption to begin a feasibility
  clinical study of the OmniVu Lens System; the device is investigational and is not approved for sale or use in the United
  States. Atia Vision is an implantable-device manufacturer: it publishes no developer program, no public API, and no machine-readable
  specification.'
url: https://raw.githubusercontent.com/api-evangelist/atia-vision/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-listing: https://forgeglobal.com/atia-vision_stock/
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Medical Devices
- Ophthalmology
- Intraocular Lens
- Cataract Surgery
- Health
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: 'Atia Vision is a clinical-stage implantable-device maker whose product is the OmniVu intraocular lens, not software
    — no api./docs./developer./portal. host resolves in DNS, no atiavision GitHub organization exists, no npm/PyPI package
    is published, and every path on the marketing site (including a random control path) is answered identically by a SiteGround
    `sg-captcha: challenge` interstitial, so there is no developer surface to read behind it either.'
  evidence:
  - url: https://api.github.com/orgs/atiavision
    status: 404
  - url: https://atiavision.com/openapi.json
    status: 202
  - url: https://atiavision.com/.well-known/agent-card.json
    status: 202
  - url: https://registry.npmjs.org/atia-vision
    status: 404
  checked: '2026-08-06'
common:
- type: DomainSecurity
  url: security/atia-vision-domain-security.yml
- type: Website
  url: https://atiavision.com/
- type: LinkedIn
  url: https://www.linkedin.com/company/atia-vision

Atia Vision

Kin Score

Security Posture 1

Atia Vision Domain Security

Resources

Access & Security 1

Company 2

Source (apis.yml)